EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cytomegalovirus‐RNA Accurately Identifies Clinically Significant Infection Needing Preemptive Therapy in Liver Transplanted Children: A Proof‐of‐Concept Study

Emanuele Nicastro iD, Eleonora Severi, Ilaria Passera, Michele Totaro, Lorenza Matarazzo iD, Laura Fornataro, Francesco Morotti iD, Alessandra Tebaldi, Ezio Bonanomi iD, Michela Bravi, Angelo Di Giorgio iD, Samuele Covini und 4 weitere

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Emanuele Nicastro und 15 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Hepatology, Gastroenterology and Transplantation, Hospital Papa Giovanni XXIII, Bergamo, Italy. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Liver Transplantation, Cytomegalovirus, RNA, Viral. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The study was supported by the Research Award 2019 of the European Society for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preemptive therapy (PET) is safe and effective in controlling Cytomegalovirus (CMV) infection after pediatric liver transplantation (LT) and allows to observe the kinetics of quantitative CMV‐DNA viral load till it reaches the treatment thresholds. While early detection of low‐to‐moderate CMV‐DNA levels may not indicate active viral replication, awaiting the viral load to exceed the treatment threshold may lead to viremic breakthroughs and CMV disease. We assessed the capacity of quantitative CMV‐RNA (UL21.5 mRNA) to identify active viral replication and its accuracy in identifying clinically significant CMV infection (csCMVi) needing PET in LT children. One‐hundred and forty‐four comparative quantitative CMV‐RNA and CMV‐DNA determinations were obtained from 12 children followed prospectically for 6 months after LT. Of 52 CMV‐DNA‐positive specimens, 17 (32%) were also CMV‐RNA‐positive, while CMV‐RNA was undetectable in CMV‐DNA‐negative specimens. All children with csCMVi had early detectable CMV‐RNA, peaking simultaneously to CMV‐DNA (median CMV‐DNA: 65 906 cp/mL; median CMV‐RNA: 767 cp/mL); conversely, none of those with persistently low DNAemia proved CMV‐RNA‐positive. In this first pilot study, CMV‐RNA had 100% sensitivity and specificity in identifying children needing PET after pediatric LT. The early detection of CMV‐RNA marks significant CMV infection/reactivation, thus allowing to avoid unnecessary antiviral treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsLiver TransplantationCytomegalovirusRNA, ViralHumansViral LoadMaleFemaleChildChild, PreschoolInfantDNA, ViralProof of Concept StudyAdolescentAntiviral AgentsSensitivity and Specificity

Stichwörter der Autor:innen

Cytomegalovirusepidemiologyimmune systeminfectionlatent infectionpathogenesistransplantationvirus classification

Substanzen

RNA, ViralDNA, ViralAntiviral Agents

Autor:innen und Institutionen

  • Pediatric Hepatology, Gastroenterology and Transplantation, Hospital Papa Giovanni XXIII, Bergamo, Italy.
  • Department of Pediatrics, University of Milan Bicocca, Milan, Italy.
  • Microbiology and Virology, Hospital Papa Giovanni XXIII, Bergamo, Italy.
  • Neonatology and Neonatal Intensive Care Unit, Spedali Civili Hospital, Brescia, Italy.
  • Infectious Diseases, Hospital Papa Giovanni XXIII, Bergamo, Italy.
  • Pediatric Intensive Care Unit, Hospital Papa Giovanni XXIII, Bergamo, Italy.

ORCID-Profile: Emanuele Nicastro, Lorenza Matarazzo, Francesco Morotti, Ezio Bonanomi, Angelo Di Giorgio, Domenico Pinelli, Marco Enrico Giovanni Arosio, Lorenzo D'Antiga

Förderung

  • The study was supported by the Research Award 2019 of the European Society for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN).

Zitieren

APA

Nicastro, E., Severi, E., Passera, I., Totaro, M., Matarazzo, L., Fornataro, L., Morotti, F., Tebaldi, A., Bonanomi, E., Bravi, M., Di Giorgio, A., Covini, S., Dolci, M., Pinelli, D., Arosio, M. E. G., & D'Antiga, L. (2025). Cytomegalovirus‐RNA Accurately Identifies Clinically Significant Infection Needing Preemptive Therapy in Liver Transplanted Children: A Proof‐of‐Concept Study. Journal of Medical Virology. https://doi.org/10.1002/jmv.70347

Vancouver

Nicastro E, Severi E, Passera I, Totaro M, Matarazzo L, Fornataro L, et al. Cytomegalovirus‐RNA Accurately Identifies Clinically Significant Infection Needing Preemptive Therapy in Liver Transplanted Children: A Proof‐of‐Concept Study. Journal of Medical Virology. 2025. doi:10.1002/jmv.70347

BibTeX
@article{Nicastro2025,
  author = {Nicastro, Emanuele and Severi, Eleonora and Passera, Ilaria and Totaro, Michele and Matarazzo, Lorenza and Fornataro, Laura and Morotti, Francesco and Tebaldi, Alessandra and Bonanomi, Ezio and Bravi, Michela and Di Giorgio, Angelo and Covini, Samuele and Dolci, Marta and Pinelli, Domenico and Arosio, Marco Enrico Giovanni and D'Antiga, Lorenzo},
  title = {Cytomegalovirus‐RNA Accurately Identifies Clinically Significant Infection Needing Preemptive Therapy in Liver Transplanted Children: A Proof‐of‐Concept Study},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70347}
}
Kostenlos starten →